Biotech "could have direct economic impact of up to $4 trillion a year...More than half of this direct impact could be outside human health in domains such as agriculture and food, consumer products and services, and materials and energy production."
- McKinsey & Company (McKinsey Insights)
Catalyst Pharmaceutical CPRX is a good investment, according to Joe Greenblatt. Should be held for one year